GE Adds to Cell Research Business
GE stated that Applied Precision’s technologies complement its IN Cell Analyzer Systems, a confocal microscopy–based platform for high-throughput subcellular analysis. The acquisition will add fluorescence and optical microscopy techniques to GE’s product portfolio for cellular research, including Applied Precision’s OMX 3D Structured Illumination microscopy technology, which can image cellular nanostructures, and DeltaVision deconvolution microscopy technology for improved resolution.
Chalfont St. Giles, UK 4/28/11—GE Healthcare has agreed to acquire Applied Precision for an undisclosed amount. Applied Precision supplies cellular imaging technology for the cell biology and biomedical research sectors, including high-resolution and super-resolution microscopy instruments with software and data visualization tools. The company has 130 employees and recorded 2010 revenues of $37 million, with over 20% annual growth. “Applied Precision is a company with a strong reputation for innovation and is a great strategic fit with our Cell Technologies business,“ said Kieran Murphy, president and CEO of GE Healthcare Life Sciences. GE stated that it plans to keep the Applied Precision facility in Issaquah, Washington State. The acquisition is expected to close in the second quarter.
